Cellular immunity, also known as cell-mediated immunity, is a vital component of the immune system responsible for defending the body against intracellular pathogens, abnormal cells, and various threats. Key players in cellular immunity are T lymphocytes (T cells), which are crucial for orchestrating and executing immune responses. Cellular immunity involves the recognition of antigens presented by infected or abnormal cells. Antigen-presenting cells, such as macrophages and dendritic cells, process and present antigens to T cells. This interaction activates cytotoxic T cells, which directly attack and destroy infected or abnormal cells. Helper T cells play a regulatory role by coordinating immune responses and enhancing the activity of other immune cells. Major histocompatibility complex (MHC) molecules facilitate the presentation of antigens to T cells, ensuring specificity in the immune response. Cytokines, signaling proteins released by immune cells, modulate cellular immunity, influencing the activation, proliferation, and function of T cells. Cellular immunity is crucial for eliminating viruses, intracellular bacteria, and cancer cells. Dysfunction in cellular immunity can lead to increased susceptibility to infections and the development of certain cancers. Understanding cellular immunity is essential for vaccine development, immunotherapy, and managing various immune-related disorders.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States